Results for acetyl-11-keto-beta-boswellic acid

The protective effect of 11-keto-β-boswellic acid against diabetic cardiomyopathy in rats entails activation of AMPK.

Article Published Date : Mar 28, 2023
Study Type : Animal Study
Additional Links
Substances : acetyl-11-keto-beta-boswellic acid
Diseases : Cardiomyopathy : CK(390) : AC(171)
Pharmacological Actions : Anti-Inflammatory Agents : CK(39737) : AC(15858), Antioxidants : CK(34551) : AC(14499), Cardioprotective : CK(9504) : AC(2963), Interleukin-6 Downregulation : CK(9337) : AC(3613), Tumor Necrosis Factor (TNF) Alpha Inhibitor : CK(11697) : AC(4806)

11-keto-α-boswellic acid has chemotaxonomic potential and antitumor activity against triple-negative breast cancer cells.

Article Published Date : Jan 11, 2021
Study Type : In Vitro Study
Additional Links
Substances : acetyl-11-keto-beta-boswellic acid
Diseases : Breast Cancer: Triple Negative : CK(970) : AC(659)
Pharmacological Actions : Apoptotic : CK(9585) : AC(7379)

3-O-acetyl-11-keto-β-boswellic acid exerts anti-tumor effects in glioblastoma cells.

Article Published Date : Jul 02, 2018
Study Type : In Vitro Study
Additional Links
Substances : acetyl-11-keto-beta-boswellic acid
Diseases : Glioblastoma : CK(729) : AC(403)
Pharmacological Actions : Antiproliferative : CK(10001) : AC(7491), Cell cycle arrest : CK(2120) : AC(1715)

Acetyl-11-Keto- β-boswellic acid (AKBA) prevents lipopolysaccharide-induced inflammation and cytotoxicity on H9C2 cells.

Article Published Date : Dec 31, 2021
Study Type : In Vitro Study
Additional Links
Substances : acetyl-11-keto-beta-boswellic acid
Diseases : Inflammation : CK(16108) : AC(5498), Lipopolysaccharide-Induced Toxicity : CK(3229) : AC(1875)
Pharmacological Actions : Anti-Inflammatory Agents : CK(39737) : AC(15858), Interleukin-1 beta downregulation : CK(6063) : AC(2940), Interleukin-6 Downregulation : CK(9337) : AC(3613), Postaglandin PGE2 downregulation : CK(386) : AC(199), Tumor Necrosis Factor (TNF) Alpha Inhibitor : CK(11697) : AC(4806)

Acetyl-11-keto-beta boswellic acid can serve as an effective basis for developing a novel OCD treatment.

Article Published Date : Aug 04, 2023
Study Type : Animal Study
Additional Links
Substances : acetyl-11-keto-beta-boswellic acid
Diseases : Obsessive-Compulsive Disorder : CK(422) : AC(78)
Pharmacological Actions : Antioxidants : CK(34551) : AC(14499), Heme oxygenase-1 up-regulation : CK(1336) : AC(776), Nrf2 activation : CK(3156) : AC(1794)

Acetyl-11-keto-beta boswellic acid mediated neuroprotection in methyl mercury-induced experimental model of ALS.

Article Published Date : May 31, 2021
Study Type : In Vitro Study
Additional Links
Substances : acetyl-11-keto-beta-boswellic acid
Diseases : Amyotrophic Lateral Sclerosis : CK(803) : AC(216), Mercury Poisoning : CK(546) : AC(159)
Pharmacological Actions : Antioxidants : CK(34551) : AC(14499), Heme oxygenase-1 up-regulation : CK(1336) : AC(776), Neuroprotective Agents : CK(20061) : AC(7949), Nrf2 activation : CK(3156) : AC(1794)
Additional Keywords : Methylmercury : CK(68) : AC(28), Remyelination : CK(48) : AC(26)
Problem Substances : Mercury : CK(889) : AC(215)

Acetyl-11-keto-beta-boswellic acid has therapeutic benefits for NAFLD.

Article Published Date : Jun 12, 2023
Study Type : Animal Study
Additional Links
Substances : acetyl-11-keto-beta-boswellic acid
Diseases : High Fructose Diet : CK(474) : AC(187), Nonalcoholic fatty liver disease (NAFLD) : CK(3451) : AC(969)
Pharmacological Actions : Anti-Inflammatory Agents : CK(39737) : AC(15858), Hepatoprotective : CK(8989) : AC(3831), Hypolipidemic : CK(9173) : AC(2038)

Acetyl-11-keto-beta-boswellic acid inhibits cell proliferation and growth of oral squamous cell carcinoma.

Article Published Date : Mar 31, 2024
Study Type : In Vitro Study
Additional Links
Substances : acetyl-11-keto-beta-boswellic acid
Diseases : Oral Cancer : CK(717) : AC(384), Squamous cell carcinoma : CK(676) : AC(348)
Pharmacological Actions : Antiproliferative : CK(10001) : AC(7491)

Acetyl-11-keto-beta-boswellic acid is a promising therapeutic agent to promote sciatic nerve repair by alleviating excessive oxidative stress.

Article Published Date : Aug 22, 2023
Study Type : Animal Study
Additional Links
Substances : acetyl-11-keto-beta-boswellic acid
Diseases : Sciatic Nerve Crush Injury : CK(211) : AC(104)
Pharmacological Actions : Anti-Apoptotic : CK(5568) : AC(3160), Antioxidants : CK(34551) : AC(14499), Heme oxygenase-1 up-regulation : CK(1336) : AC(776), Nrf2 activation : CK(3156) : AC(1794)
Additional Keywords : Nerve Regeneration : CK(372) : AC(193)

Acetyl-11-keto-beta-boswellic acid modulates macrophage polarization and Schwann cell migration to accelerate spinal cord injury repair.

Article Published Date : Feb 29, 2024
Study Type : Animal Study
Additional Links
Substances : acetyl-11-keto-beta-boswellic acid
Diseases : Spinal Cord Injuries : CK(890) : AC(347)
Pharmacological Actions : Antioxidants : CK(34551) : AC(14499), Neuroprotective Agents : CK(20061) : AC(7949)

Acetyl-11-keto-beta-boswellic acid promotes sciatic nerve repair after injury.

Article Published Date : Nov 30, 2022
Study Type : Animal Study
Additional Links
Substances : acetyl-11-keto-beta-boswellic acid
Diseases : Sciatic Nerve Crush Injury : CK(211) : AC(104)
Pharmacological Actions : Anti-Inflammatory Agents : CK(39737) : AC(15858), Interleukin-1 beta downregulation : CK(6063) : AC(2940)
Additional Keywords : Nerve Regeneration : CK(372) : AC(193)

Acetyl-11-Keto-β-boswellic acid accelerates the repair of spinal cord injury.

Article Published Date : Dec 25, 2023
Study Type : Animal Study
Additional Links
Substances : acetyl-11-keto-beta-boswellic acid
Diseases : Spinal Cord Injuries : CK(890) : AC(347)
Pharmacological Actions : Anti-Inflammatory Agents : CK(39737) : AC(15858), Interleukin-18 down-regulation : CK(372) : AC(183), Interleukin-1 beta downregulation : CK(6063) : AC(2940), Neuroprotective Agents : CK(20061) : AC(7949)

Acetyl-11-keto-β-boswellic acid ameliorates cognitive deficits and reduces amyloid-β levels.

Article Published Date : Mar 31, 2020
Study Type : Animal Study
Additional Links
Substances : acetyl-11-keto-beta-boswellic acid
Diseases : Alzheimer's Disease : CK(5355) : AC(2210)
Pharmacological Actions : Anti-Inflammatory Agents : CK(39737) : AC(15858), Antioxidants : CK(34551) : AC(14499), Heme oxygenase-1 up-regulation : CK(1336) : AC(776), Neuroprotective Agents : CK(20061) : AC(7949), Nrf2 activation : CK(3156) : AC(1794)

Acetyl-11-keto-β-boswellic acid confers protection in DSS-induced colitis.

Article Published Date : May 31, 2023
Study Type : Animal Study
Additional Links
Substances : acetyl-11-keto-beta-boswellic acid
Diseases : Colitis : CK(1542) : AC(735), Inflammatory Bowel Diseases : CK(3196) : AC(926)
Pharmacological Actions : Anti-Inflammatory Agents : CK(39737) : AC(15858), Gastroprotective : CK(1692) : AC(701), NF-kappaB Inhibitor : CK(5952) : AC(3464)

Acetyl-11-keto-β-boswellic acid could be a promising chemotherapy treatment for glioblastoma.

Article Published Date : Jan 31, 2020
Study Type : In Vitro Study
Additional Links
Substances : acetyl-11-keto-beta-boswellic acid
Diseases : Glioblastoma : CK(729) : AC(403)
Pharmacological Actions : Autophagy Inhibitors : CK(302) : AC(188), Chemotherapeutic : CK(4390) : AC(1635)

Acetyl-11-keto-β-boswellic acid exerts the anti-cancer effects via cell cycle arrest, apoptosis induction, and autophagy suppression in NSCLC cells.

Article Published Date : Dec 31, 2019
Study Type : In Vitro Study
Additional Links
Substances : acetyl-11-keto-beta-boswellic acid
Diseases : Carcinoma: Non-Small-Cell Lung : CK(710) : AC(428)
Pharmacological Actions : Antiproliferative : CK(10001) : AC(7491), Apoptotic : CK(9585) : AC(7379), Cell cycle arrest : CK(2120) : AC(1715)

Acetyl-11-keto-β-boswellic acid extracted from Boswellia serrata promotes Schwann cell proliferation and sciatic nerve function recovery.

Article Published Date : Feb 28, 2018
Study Type : Animal Study
Additional Links
Substances : acetyl-11-keto-beta-boswellic acid, Frankincense : CK(1021) : AC(260)
Pharmacological Actions : Regenerative : CK(486) : AC(201)
Additional Keywords : Nerve Regeneration : CK(372) : AC(193)

Acetyl-11-keto-β-boswellic acid improves clinical symptoms through modulation of Nrf2 and NF-κB pathways.

Article Published Date : Mar 16, 2022
Study Type : Animal Study
Additional Links
Substances : acetyl-11-keto-beta-boswellic acid
Diseases : Multiple Sclerosis : CK(2432) : AC(557)
Pharmacological Actions : Anti-Inflammatory Agents : CK(39737) : AC(15858), Antioxidants : CK(34551) : AC(14499), NF-kappaB Inhibitor : CK(5952) : AC(3464), Nrf2 activation : CK(3156) : AC(1794)

Acetyl-11-keto-β-boswellic acid inhibits precancerous breast lesion MCF-10AT cells.

Article Published Date : Dec 31, 2019
Study Type : In Vitro Study
Additional Links
Substances : acetyl-11-keto-beta-boswellic acid
Diseases : Breast Cancer : CK(8297) : AC(3043)
Pharmacological Actions : Antiproliferative : CK(10001) : AC(7491), Apoptotic : CK(9585) : AC(7379), Cell cycle arrest : CK(2120) : AC(1715), Chemopreventive : CK(6580) : AC(2166), MicroRNA modulator : CK(1560) : AC(897)

Acetyl-11-keto-β-boswellic acid inhibits proliferation and induces apoptosis of gastric cancer cells.

Article Published Date : Oct 13, 2020
Study Type : In Vitro Study
Additional Links
Substances : acetyl-11-keto-beta-boswellic acid
Diseases : Gastric Cancer : CK(1619) : AC(725)
Pharmacological Actions : Antiproliferative : CK(10001) : AC(7491), Apoptotic : CK(9585) : AC(7379), Cyclooxygenase 2 Inhibitors : CK(2264) : AC(1327)

Acetyl-11-keto-β-boswellic acid may be a potential anabolic agent in the treatment of rheumatoid arthritis-derived bone loss disease.

Article Published Date : Sep 30, 2018
Study Type : In Vitro Study
Additional Links
Substances : acetyl-11-keto-beta-boswellic acid
Diseases : Rheumatoid Arthritis : CK(2322) : AC(562)
Pharmacological Actions : Anti-Inflammatory Agents : CK(39737) : AC(15858), NF-kappaB Inhibitor : CK(5952) : AC(3464), Tumor Necrosis Factor (TNF) Alpha Inhibitor : CK(11697) : AC(4806)

Acetyl-11-keto-β-boswellic acid may serve as a promising treatment for age-related cataract progression.

Article Published Date : Dec 31, 2021
Study Type : Animal Study, In Vitro Study
Additional Links
Substances : acetyl-11-keto-beta-boswellic acid
Diseases : Cataract : CK(444) : AC(123), Hydrogen Peroxide Induced Toxicity : CK(437) : AC(349)
Pharmacological Actions : Antioxidants : CK(34551) : AC(14499), Heme oxygenase-1 up-regulation : CK(1336) : AC(776), Nrf2 activation : CK(3156) : AC(1794)

Acetyl-11-keto-β-boswellic acid restores altered neurochemical levels, potentially preventing gross pathological abnormalities during MS progression.

Article Published Date : Jul 24, 2022
Study Type : Animal Study
Additional Links
Substances : acetyl-11-keto-beta-boswellic acid
Diseases : Multiple Sclerosis : CK(2432) : AC(557)
Pharmacological Actions : Anti-Inflammatory Agents : CK(39737) : AC(15858), Antioxidants : CK(34551) : AC(14499), Heme oxygenase-1 up-regulation : CK(1336) : AC(776), Nrf2 activation : CK(3156) : AC(1794)

Acetyl-11-keto-β-boswellic acid showed good antiosteoporotic activity.

Article Published Date : Oct 17, 2020
Study Type : Animal Study
Additional Links
Substances : acetyl-11-keto-beta-boswellic acid
Diseases : Osteoporosis : CK(2786) : AC(758)
Pharmacological Actions : Anti-Inflammatory Agents : CK(39737) : AC(15858), NF-kappaB Inhibitor : CK(5952) : AC(3464), Osteoprotective : CK(2037) : AC(685), Tumor Necrosis Factor (TNF) Alpha Inhibitor : CK(11697) : AC(4806)

Acetyl-11-keto-β-boswellic acid suppresses docetaxel-resistant prostate cancer cells.

Article Published Date : Aug 30, 2018
Study Type : Animal Study, In Vitro Study
Additional Links
Substances : acetyl-11-keto-beta-boswellic acid
Diseases : Cancers: Drug Resistant : CK(924) : AC(668), Prostate Cancer : CK(2805) : AC(1046)
Pharmacological Actions : Antiproliferative : CK(10001) : AC(7491)
Additional Keywords : Cancer Stem Cells : CK(501) : AC(365)

Acetyl-11-keto-β-boswellic acid suppresses invasion of pancreatic cancer cells.

Article Published Date : Jun 30, 2011
Study Type : In Vitro Study
Additional Links
Substances : acetyl-11-keto-beta-boswellic acid
Diseases : Pancreatic Cancer : CK(1547) : AC(564)
Pharmacological Actions : Anti-metastatic : CK(2870) : AC(2182)

Acetyl‐11‐keto‐β‐boswellic acid ameliorates renal interstitial fibrosis.

Article Published Date : Sep 30, 2018
Study Type : In Vitro Study
Additional Links
Substances : acetyl-11-keto-beta-boswellic acid
Diseases : Fibrosis : CK(383) : AC(185)
Pharmacological Actions : Anti-Fibrotic : CK(2209) : AC(1052)

Anti-diabetic potential of β-boswellic acid and 11-keto-β-boswellic acid.

Article Published Date : Feb 28, 2022
Study Type : In Vitro Study
Additional Links
Substances : acetyl-11-keto-beta-boswellic acid, Frankincense : CK(1021) : AC(260)
Diseases : Hyperglycemia : CK(2240) : AC(709)
Pharmacological Actions : Antihypertensive Agents : CK(7081) : AC(1029), Antioxidants : CK(34551) : AC(14499), Malondialdehyde Down-regulation : CK(3028) : AC(992), Superoxide Dismutase Up-regulation : CK(2383) : AC(928)
Additional Keywords : Plant Extracts : CK(18762) : AC(6782)

Anti-proliferative, pro-apoptotic, and chemosensitizing potential of 3-Acetyl-11-keto-β-boswellic acid against prostate cancer cells.

Article Published Date : Mar 18, 2024
Study Type : In Vitro Study
Additional Links
Substances : acetyl-11-keto-beta-boswellic acid
Diseases : Prostate Cancer : CK(2805) : AC(1046)
Pharmacological Actions : Antiproliferative : CK(10001) : AC(7491), Apoptotic : CK(9585) : AC(7379), Chemosensitizer : CK(1657) : AC(1270)

Antioxidant effects of hydroxysafflor yellow A and acetyl-11-keto-β-boswellic acid in combination on isoproterenol-induced myocardial injury.

Article Published Date : May 31, 2016
Study Type : Animal Study
Additional Links
Substances : acetyl-11-keto-beta-boswellic acid, Safflower : CK(374) : AC(187)
Diseases : Hypoxia : CK(436) : AC(244), Myocardial Ischemia : CK(1001) : AC(460), Oxidative Stress : CK(14758) : AC(5716)
Pharmacological Actions : Anti-Apoptotic : CK(5568) : AC(3160), Antioxidants : CK(34551) : AC(14499), Cardioprotective : CK(9504) : AC(2963), Malondialdehyde Down-regulation : CK(3028) : AC(992), Nrf2 activation : CK(3156) : AC(1794), Superoxide Dismutase Up-regulation : CK(2383) : AC(928)

B. sernata and AKBA reduce neuronal cell death induced by OGSD and this neuroprotective effect is mediated via attenuation of oxidative stress.

Article Published Date : Apr 30, 2017
Study Type : In Vitro Study
Additional Links
Substances : acetyl-11-keto-beta-boswellic acid, Frankincense : CK(1021) : AC(260)
Diseases : Brain Ischemia : CK(582) : AC(255), DNA damage : CK(2301) : AC(842), Lipid Peroxidation : CK(2057) : AC(806), Oxidative Stress : CK(14758) : AC(5716)
Pharmacological Actions : Anti-Apoptotic : CK(5568) : AC(3160), Antioxidants : CK(34551) : AC(14499), Neuroprotective Agents : CK(20061) : AC(7949)
Additional Keywords : Phytotherapy : CK(4003) : AC(1031), Plant Extracts : CK(18762) : AC(6782)

Boswellia serrata extract containing 30% 3-Acetyl-11-keto-boswellic acid attenuates inflammatory mediators.

Article Published Date : Dec 31, 2020
Study Type : In Vitro Study
Additional Links
Substances : acetyl-11-keto-beta-boswellic acid, Frankincense : CK(1021) : AC(260)
Diseases : Arthritis : CK(5826) : AC(1505)
Pharmacological Actions : Anti-Inflammatory Agents : CK(39737) : AC(15858), Postaglandin PGE2 downregulation : CK(386) : AC(199)

Boswellic acid inhibits growth and metastasis of human colorectal cancer.

Article Published Date : Apr 30, 2012
Study Type : Animal Study
Additional Links
Substances : acetyl-11-keto-beta-boswellic acid, Frankincense : CK(1021) : AC(260)
Diseases : Cancer Metastasis : CK(961) : AC(542), Colorectal Cancer : CK(4889) : AC(2276)
Pharmacological Actions : Anti-Inflammatory Agents : CK(39737) : AC(15858), Anti-metastatic : CK(2870) : AC(2182), Antiproliferative : CK(10001) : AC(7491), Cyclooxygenase 2 Inhibitors : CK(2264) : AC(1327), Enzyme Inhibitors : CK(846) : AC(399)

Boswellic extracts and 11-keto-ß-boswellic acids prevent type 1 and type 2 diabetes mellitus by suppressing the expression of proinflammatory cytokines.

Article Published Date : Jun 27, 2019
Study Type : Review
Additional Links
Substances : acetyl-11-keto-beta-boswellic acid, Frankincense : CK(1021) : AC(260)
Diseases : Diabetes Mellitus: Type 1 : CK(2032) : AC(611), Diabetes Mellitus: Type 2 : CK(12953) : AC(2579)
Pharmacological Actions : Anti-Inflammatory Agents : CK(39737) : AC(15858), Interleukin-1 beta downregulation : CK(6063) : AC(2940), Tumor Necrosis Factor (TNF) Alpha Inhibitor : CK(11697) : AC(4806)

Chloroform extract and acetyl-11-keto-beta-boswellic acid from Boswellia dalzielii stem bark induce apoptosis and cell cycle blockage in AW8507 cells.

Article Published Date : Aug 08, 2021
Study Type : In Vitro Study
Additional Links
Substances : acetyl-11-keto-beta-boswellic acid, Frankincense : CK(1021) : AC(260)
Diseases : Head and Neck Cancer : CK(797) : AC(189)
Pharmacological Actions : Antiproliferative : CK(10001) : AC(7491), Apoptotic : CK(9585) : AC(7379), Cell cycle arrest : CK(2120) : AC(1715)
Additional Keywords : Plant Extracts : CK(18762) : AC(6782)

Combined acetyl-11-keto-β-boswellic acid and radiation treatment inhibited glioblastoma tumor cells

Article Published Date : Dec 31, 2017
Study Type : Animal Study, In Vitro Study
Additional Links
Substances : acetyl-11-keto-beta-boswellic acid
Diseases : Glioblastoma : CK(729) : AC(403)
Pharmacological Actions : Antiproliferative : CK(10001) : AC(7491), Radiosensitizer : CK(372) : AC(247)

Constitutes of Boswellia serrata extract act synergistically to exert anti-inflammatory/anti-arthritic activity.

Article Published Date : Mar 05, 2019
Study Type : Human Study
Additional Links
Substances : acetyl-11-keto-beta-boswellic acid, Frankincense : CK(1021) : AC(260)
Diseases : Osteoarthritis: Knee : CK(2345) : AC(276)
Pharmacological Actions : Anti-Inflammatory Agents : CK(39737) : AC(15858)
Additional Keywords : Natural Substance Synergy : CK(1400) : AC(669)

Evaluation of the solubility of 11-keto-β-boswellic acid and its histological effect on the diabetic mice liver using a novel technique.

Article Published Date : Jun 30, 2021
Study Type : Animal Study
Additional Links
Substances : acetyl-11-keto-beta-boswellic acid
Diseases : Diabetic Complications : CK(4678) : AC(1606), Liver Damage : CK(4109) : AC(1872)
Pharmacological Actions : Hepatoprotective : CK(8989) : AC(3831)

Frankincense Superior to Chemotherapy in Killing Late-Stage Ovarian Cancer Cells

Post date:
Tuesday, March 28, 2023 - 05:47
This article is copyrighted by GreenMedInfo LLC, 2023
Visit our Re-post guidelines

Like the Magi, carrying myrrh, frankincense, and gold, researchers from the University of Leicester have, for the first time, demonstrated the potential of treating ovarian cancer using the Christmas gift frankincense.

The origins of frankincense can be traced to the Arabian Peninsula. According to Herodotus (5th century BC):

Read more

Inhibitory effect of acetyl-11-keto-β-boswellic acid on titanium particle-induced bone loss.

Article Published Date : Apr 30, 2021
Study Type : In Vitro Study
Additional Links
Substances : acetyl-11-keto-beta-boswellic acid
Diseases : Titanium Toxicity : CK(31) : AC(18)
Pharmacological Actions : Osteoprotective : CK(2037) : AC(685)
Problem Substances : Titanium Nanoparticles : CK(39) : AC(24)

Neuro-protective effect of Acetyl-11-keto-β-boswellic acid in a model of scopolamine-induced cholinergic dysfunction.

Article Published Date : Dec 31, 2023
Study Type : Animal Study
Additional Links
Substances : acetyl-11-keto-beta-boswellic acid
Diseases : Learning disorders : CK(541) : AC(163), Memory Disorders : CK(2347) : AC(627)
Pharmacological Actions : Neuroprotective Agents : CK(20061) : AC(7949)

Protective mechanisms of 3-acetyl-11-keto-β-boswellic acid and piperine in fluid percussion rat model of traumatic brain injury.

Article Published Date : Jan 31, 2023
Study Type : Animal Study
Additional Links
Substances : acetyl-11-keto-beta-boswellic acid, Piperine : CK(600) : AC(258)
Diseases : Brain Injury: Traumatic : CK(383) : AC(131)
Pharmacological Actions : Anti-Inflammatory Agents : CK(39737) : AC(15858), NF-kappaB Inhibitor : CK(5952) : AC(3464)

Structural and mechanistic insights into 5-lipoxygenase inhibition by natural products.

Article Published Date : May 10, 2020
Study Type : In Vitro Study
Additional Links
Substances : acetyl-11-keto-beta-boswellic acid
Diseases : Inflammation : CK(16108) : AC(5498)
Pharmacological Actions : 5-Lipoxygenase Inhibitor : CK(48) : AC(31)

Sublingual AKBA exerts antidepressant effects in the Aβ-treated mouse model.

Article Published Date : May 02, 2021
Study Type : Animal Study
Additional Links
Substances : acetyl-11-keto-beta-boswellic acid
Diseases : Depression : CK(9574) : AC(1756)
Pharmacological Actions : Antidepressive Agents : CK(7918) : AC(1467)

The effects of acetyl-11-keto-β-boswellic acid on brain cytokines and memory impairment induced by lipopolysaccharide.

Article Published Date : Jun 30, 2020
Study Type : Animal Study
Additional Links
Substances : acetyl-11-keto-beta-boswellic acid
Diseases : Lipopolysaccharide-Induced Toxicity : CK(3229) : AC(1875), Memory Disorders : CK(2347) : AC(627)
Pharmacological Actions : Anti-Inflammatory Agents : CK(39737) : AC(15858), Antioxidants : CK(34551) : AC(14499), Interleukin-10 upregulation : CK(1296) : AC(436), Interleukin-6 Downregulation : CK(9337) : AC(3613), Neuroprotective Agents : CK(20061) : AC(7949), Tumor Necrosis Factor (TNF) Alpha Inhibitor : CK(11697) : AC(4806)

This study implied that acetyl-11-keto-β-boswellic acid might have an anti-inflammatory effect on psoriasis.

Article Published Date : Aug 14, 2018
Study Type : In Vitro Study
Additional Links
Substances : acetyl-11-keto-beta-boswellic acid
Diseases : Inflammation : CK(16108) : AC(5498), Psoriasis : CK(922) : AC(255)
Pharmacological Actions : Anti-Inflammatory Agents : CK(39737) : AC(15858), Interleukin-12 downregulation : CK(203) : AC(77), Interleukin-23 Downregulation : CK(107) : AC(42)

Connect with GreenMedInfo